The February issue of Transfusion Journal, features James Stubbs’, M.D., Chair of the Mayo Clinic Division of Transfusion Medicine, article, “Wrapping our arms around the cost of transfusion therapy.”
According to the article, “In most developed countries, health care spending increases at a more rapid rate than the gross domestic product (GDP). In the United States, the health spending-to-GDP ratio has reached 17.9%. The Center for Medicare and Medicaid Services estimates that this ratio will reach 19.6% by the year 2021.”
Due to the increase in health care spending, the costs of blood transfusion are also on the rise, which results in the need for a cost-effective evaluation of transfusion therapy.
The article discusses various studies that can help those involved in the practice of transfusion medicine to better understand the total cost and variability of costs associated with transfusion therapy.